Literature DB >> 23644141

Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat.

Lan Zhang1, Huiying Zhao, Xiangjian Zhang, Linyu Chen, Xumeng Zhao, Xue Bai, Jian Zhang.   

Abstract

There is cumulative evidence that the serine-threonine kinase Akt and its downstream nuclear transcription factor CREB are involved in neuronal survival and protection. The Akt activates and phosphorylates CREB at Ser133, resulting in the up-regulation of pro-survival CREB target genes such as BDNF and Bcl-2. Thus, Akt/CREB signaling pathway may be one propitious target for treatment of ischemic cerebral injury. Nobiletin (NOB) exhibits a wide spectrum of beneficial biological properties including anti-inflammatory, antioxidant, anti-carcinogenic actions and contributes to reverse learning impairment in Alzheimer's disease rat. However, little is currently known regarding the exact role of NOB in ischemic stroke. Here, we designed to evaluate its possible therapeutic effect on cerebral ischemia. Adult male Sprague-Dawley rats were subjected to permanent middle cerebral artery occlusion (pMCAO) and randomly divided into five groups: Sham (sham-operated+0.05% Tween-80), MCAO (pMCAO+0.9% saline), Vehicle group (pMCAO+0.05% Tween-80), NOB-L (pMCAO+NOB 10 mg/kg) and NOB-H (pMCAO+NOB 25 mg/kg) groups. Rats were pre-administered intraperitoneally once daily for 3 days before surgery and then received once again immediately after surgery. Neurological deficit scores, brain water content and infarct volume were evaluated at 24 h after stroke. Additionally, the activities of Akt, CREB, BDNF, Bcl-2 and claudin-5 in ischemic brain cortex were analyzed by the methods of immunohistochemistry, western blot and RT-qPCR. Compared with Vehicle group, neurological deficits and brain edema were relieved in NOB-H group (P<0.05), infarct volume was lessened in both NOB-L and NOB-H groups (P<0.05) at 24 h after stroke. Immunohistochemistry, western blot and RT-qPCR analysis indicated that NOB dramatically promoted the activities of Akt, CREB, BDNF and Bcl-2 (P<0.05). Meanwhile, claudin-5 expression was also enhanced. On the basis of these findings, we concluded that NOB protected the brain from ischemic damage and it maybe through activating the Akt/CREB signaling pathway and ameliorating BBB permeability.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt/CREB; BDNF; Bcl-2; Ischemic stroke; Neuroprotection; Nobiletin

Mesh:

Substances:

Year:  2013        PMID: 23644141     DOI: 10.1016/j.brainresbull.2013.04.009

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  31 in total

1.  Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy.

Authors:  Ning Zhang; Zheng Yang; Shi-Zhao Xiang; Ya-Ge Jin; Wen-Ying Wei; Zhou-Yan Bian; Wei Deng; Qi-Zhu Tang
Journal:  Mol Cell Biochem       Date:  2016-05-10       Impact factor: 3.396

Review 2.  Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.

Authors:  Yong Gu; Jianping Chen; Jiangang Shen
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-22       Impact factor: 4.147

3.  PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling.

Authors:  M Mueller; A Schoeberlein; J Zhou; M Joerger-Messerli; B Oppliger; U Reinhart; A Bordey; D Surbek; E R Barnea; Y Huang; M Paidas
Journal:  Cell Death Differ       Date:  2015-05-15       Impact factor: 15.828

4.  Time-course investigation of blood-brain barrier permeability and tight junction protein changes in a rat model of permanent focal ischemia.

Authors:  Peng Liu; Rui Zhang; Danyang Liu; Jinling Wang; Chunling Yuan; Xuemei Zhao; Yinjie Li; Xuefei Ji; Tianyan Chi; Libo Zou
Journal:  J Physiol Sci       Date:  2017-01-11       Impact factor: 2.781

5.  Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-κB, MMP-9 and up-regulated claudin-5 expression.

Authors:  Xue Bai; Xiangjian Zhang; Linyu Chen; Jian Zhang; Lan Zhang; Xumeng Zhao; Ting Zhao; Yuan Zhao
Journal:  Neurochem Res       Date:  2014-05-20       Impact factor: 3.996

6.  Nobiletin alleviates cerebral ischemic-reperfusion injury via MAPK signaling pathway.

Authors:  Tao Wang; Feng Wang; Lu Yu; Zaiwang Li
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

7.  Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats.

Authors:  Qing Mao; Xiulin Liang; Yufu Wu; Yongxiang Lu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-09       Impact factor: 3.000

8.  Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.

Authors:  Jing-Hui Song; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-10-30       Impact factor: 5.590

9.  Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model.

Authors:  Amutha Selvamani; Madison H Williams; Rajesh C Miranda; Farida Sohrabji
Journal:  Clin Sci (Lond)       Date:  2014-07       Impact factor: 6.124

10.  Nimodipine promotes neurite outgrowth and protects against neurotoxicity in PC12 cells.

Authors:  Miduki Kusakabe; Yasushi Hasegawa
Journal:  Iran J Basic Med Sci       Date:  2021-01       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.